CoChat

n-3 Fatty Acid Biomarkers and Incident Type 2 Diabetes: An Individual Participant-Level Pooling Project of 20 Prospective Cohort Studies

Open access
Qian, Frank, Ardisson Korat, Andres V., Imamura, Fumiaki, Marklund, Matti, Tintle, Nathan, Virtanen, Jyrki K., Zhou, Xia, Bassett, Julie K., Lai, Heidi, Hirakawa, Yoichiro, Chien, Kuo-Liong, Wood, Alexis C., Lankinen, Maria, Murphy, Rachel A., Samieri, Cecilia, Pertiwi, Kamalita, de Mello, Vanessa D., Guan, Weihua, Forouhi, Nita G., Wareham, Nick, Hu, InterAct Consortium, Frank B., Riserus, Ulf, Lind, Lars, Harris, William S., Shadyab, Aladdin H., Robinson, Jennifer G., Steffen, Lyn M., Hodge, Allison, Giles, Graham G., Ninomiya, Toshiharu, Uusitupa, Matti, Tuomilehto, Jaakko, Lindström, Jaana, Laakso, Markku, Siscovick, David S., Helmer, Catherine, Geleijnse, Johanna M., Wu, Jason H.Y., Fretts, Amanda, Lemaitre, Rozenn N., Micha, Renata, Mozaffarian, Dariush, Sun, Qi · 2021 · Diabetes Care
Cited by 78

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Prospective associations between n-3 fatty acid biomarkers and type 2 diabetes (T2D) risk are not consistent in individual studies. We aimed to summarize the prospective associations of biomarkers of α-linolenic acid (ALA), eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA) with T2D risk through an individual participant-level pooled analysis. RESEARCH DESIGN AND METHODS: For our analysis we incorporated data from a global consortium of 20 prospective studies from 14 countries. We included 65,147 participants who had blood measurements of ALA, EPA, DPA, or DHA and were free of diabetes at baseline. De novo harmonized analyses were performed in each cohort following a prespecified protocol, and cohort-specific associations were pooled using inverse variance–weighted meta-analysis. RESULTS: A total of 16,693 incident T2D cases were identified during follow-up (median follow-up ranging from 2.5 to 21.2 years). In pooled multivariable analysis, per interquintile range (difference between the 90th and 10th percentiles for each fatty acid), EPA, DPA, DHA, and their sum were associated with lower T2D incidence, with hazard ratios (HRs) and 95% CIs of 0.92 (0.87, 0.96), 0.79 (0.73, 0.85), 0.82 (0.76, 0.89), and 0.81 (0.75, 0.88), respectively (all P < 0.001). ALA was not associated with T2D (HR 0.97 [95% CI 0.92, 1.02]) per interquintile range. Associations were robust across prespecified subgroups as well as in sensitivity analyses. CONCLUSIONS: Higher circulating biomarkers of seafood-derived n-3 fatty acids, including EPA, DPA, DHA, and their sum, were associated with lower risk of T2D in a global consortium of prospective studies. The biomarker of plant-derived ALA was not significantly associated with T2D risk.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc20-2426

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 78

Metadata

Authors
Qian, F., Ardisson Korat, A. V., Imamura, F., Marklund, M., Tintle, N., Virtanen, J. K., Zhou, X., Bassett, J. K., Lai, H., Hirakawa, Y., Chien, K.-L., Wood, A. C., Lankinen, M., Murphy, R. A., Samieri, C., Pertiwi, K., de Mello, V. D., Guan, W., Forouhi, N. G., Wareham, N., Hu, I. C., Riserus, U., Lind, L., Harris, W. S., Shadyab, A. H., Robinson, J. G., Steffen, L. M., Hodge, A., Giles, G. G., Ninomiya, T., Uusitupa, M., Tuomilehto, J., Lindström, J., Laakso, M., Siscovick, D. S., Helmer, C., Geleijnse, J. M., Wu, J. H. Y., Fretts, A., Lemaitre, R. N., Micha, R., Mozaffarian, D., & Sun, Q.
Venue
Diabetes Care
Published
2021-03-03
Volume
44
Issue
5
Pages
1133-1142
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W3133745243
Cited by
78
References
14
FWCI
8.20
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.